| Cat.No. | Name | Information |
|---|---|---|
| M49469 | CKD-702 | CKD-702 is a c-Met/EGFR bispecific antibody that can be used in studies related to non-small cell lung cancer and gastric cancer. |
| M49455 | CALY-002 | CALY-002 is a potential best-in-class (BIC), humanized monoclonal antibody targeting IL-15 for studies related to immune diseases. |
| M49447 | GS-1811 | GS-1811 is a monoclonal antibody targeting CCR8 that selectively removes tumor-infiltrating T regulatory cells with immunosuppressive effects in the tumor microenvironment, and can be used in studies related to solid tumors. |
| M49444 | BAY-3375968 | BAY-3375968 is a monoclonal antibody targeting the CCR8 receptor that selectively reduces CCR8-positive Tregs through antibody-dependent cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP), and can be used in studies related to solid tumors. |
| M49442 | BMS-986340 | BMS-986340 is a human immunoglobulin G1 (IgG1) non-fucosylated (NF) monoclonal antibody to CCR8 that targets, binds to, and blocks CCR8 activity on CCR8-positive tumor-infiltrating regulatory T-cells (Tregs) in tumor microenvironments (TMEs) and prevents chemokine ligand (CCL1-CCR8)-mediated signaling. |
| M49437 | PF-06480605 | PF-06480605 is an IgG1 human monoclonal antibody against TNF-like ligand 1A (TL1A, TNFSF15), which can be used in studies related to ulcerative colitis (UC). |
| M49436 | V565 | V565 is a novel antibody that specifically targets TNFα and can be used in studies related to Crohn's disease (CD). |
| M49354 | Auremolimab | Auremolimab is an ultra-humanized monoclonal antibody against IL-2Rβ (CD122) that targets and depletes tissue-resident memory T-cells, and may be used in vitiligo-related studies. |
| M45367 | Genakumab | Genakumab is a monoclonal antibody targeting IL-1β that can be used in studies related to gout. |
| M45266 | Linvoseltamab | Linvoseltamab is a bispecific antibody targeting BCMA (TNFRSF17) and CD3. Linvoseltamab is used in studies related to relapsed/refractory multiple myeloma (R/R MM). |
| M45250 | DCSZ11 | DCSZ11 is a monoclonal antibody targeting CD93 for studies related to solid tumors. |
| M45249 | DCBY02 | DCBY02 is a monoclonal antibody targeting CD93 for studies related to solid tumors. |
| M45225 | NPX887 | NPX887 is a monoclonal antibody targeting the co-stimulatory molecule B7H7, which can be used in studies related to solid tumors. |
| M45224 | BI-1910 | BI-1910 is a monoclonal antibody targeting anti-tumor necrosis factor receptor 2 (TNFR2). |
| M45223 | Casdozokitug | Casdozokitug is an IgG1κ antibody targeting IL27. |
| M45222 | TEV’574 | TEV'574 is a TL1A antibody with a unique binding epitope that blocks TL1A binding to the DR3 receptor without affecting TL1A binding to the DcR3 pseudoreceptor. It can be used in studies related to ulcerative colitis and Crohn's disease. |
| M45221 | TEV-48574 | TEV-48574 is a TL1A-targeted monoclonal antibody that can be used in studies related to ulcerative colitis (UC). |
| M45160 | LY3499446 | LY3499446 is a KRAS G12C covalent inhibitor for studies related to non-small cell lung cancer (NSCLC). |
| M45157 | OS2966 | OS2966 is a first-in-class (first-in-class) neutralizing anti-CD29 monoclonal antibody that selectively modulates CD29 (integrin b1 subunit) and can be used in glioblastoma-related studies. |
| M45134 | IMVT-1402 | IMVT-1402 is a potential best-in-class (BIC) neonatal Fc receptor (FcRn)-targeting antibody for studies related to autoimmune diseases. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
